|
US7033827B2
(en)
|
1997-02-25 |
2006-04-25 |
Corixa Corporation |
Prostate-specific polynucleotide compositions
|
|
US6620922B1
(en)
|
1997-02-25 |
2003-09-16 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US7202342B1
(en)
|
1999-11-12 |
2007-04-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US20030185830A1
(en)
|
1997-02-25 |
2003-10-02 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US6800746B2
(en)
|
1997-02-25 |
2004-10-05 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US7270980B2
(en)
*
|
1997-02-25 |
2007-09-18 |
Corixa Corporation |
Compounds for immunodiagnosis of prostate cancer and methods for their use
|
|
US6759515B1
(en)
|
1997-02-25 |
2004-07-06 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US6613872B1
(en)
|
1997-02-25 |
2003-09-02 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
|
US6329505B1
(en)
|
1997-02-25 |
2001-12-11 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of prostate cancer
|
|
US6261562B1
(en)
|
1997-02-25 |
2001-07-17 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
|
US6395278B1
(en)
|
1997-02-25 |
2002-05-28 |
Corixa Corporation |
Prostate specific fusion protein compositions
|
|
US6894146B1
(en)
|
1997-02-25 |
2005-05-17 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US6818751B1
(en)
|
1997-08-01 |
2004-11-16 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US6943236B2
(en)
|
1997-02-25 |
2005-09-13 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US6630305B1
(en)
|
1999-11-12 |
2003-10-07 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US6465611B1
(en)
|
1997-02-25 |
2002-10-15 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
|
CN1195851C
(zh)
|
1997-02-25 |
2005-04-06 |
科里克萨有限公司 |
用于前列腺癌免疫疗法的化合物及其用途
|
|
US7517952B1
(en)
|
1997-02-25 |
2009-04-14 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US6365369B1
(en)
|
1998-04-01 |
2002-04-02 |
Human Genome Sciences, Inc. |
Prostate specific secreted protein
|
|
US6048970A
(en)
*
|
1998-05-22 |
2000-04-11 |
Incyte Pharmaceuticals, Inc. |
Prostate growth-associated membrane proteins
|
|
US20030149531A1
(en)
|
2000-12-06 |
2003-08-07 |
Hubert Rene S. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
|
US6833438B1
(en)
|
1999-06-01 |
2004-12-21 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
|
EP2080802B1
(en)
|
1998-06-01 |
2017-03-29 |
Agensys, Inc. |
Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
|
|
US20060052321A1
(en)
|
2002-04-05 |
2006-03-09 |
Raitano Arthur B |
Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
|
|
WO1999062942A2
(en)
*
|
1998-06-01 |
1999-12-09 |
Urogenesys, Inc. |
Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
|
|
US20040141975A1
(en)
|
1998-06-01 |
2004-07-22 |
Raitano Arthur B. |
Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
|
|
US7037667B1
(en)
|
1998-06-01 |
2006-05-02 |
Agensys, Inc. |
Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
|
|
KR20010083111A
(ko)
*
|
1998-07-14 |
2001-08-31 |
길리스 스티브 |
전립선암의 치료 및 진단을 위한 조성물 및 방법
|
|
CA2344552A1
(en)
*
|
1998-10-02 |
2000-04-13 |
Urogenesys, Inc. |
Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6
|
|
US6902892B1
(en)
|
1998-10-19 |
2005-06-07 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
|
|
US7022497B1
(en)
*
|
1999-03-11 |
2006-04-04 |
Mt. Sinai Hospital |
Human kallikrein-like genes
|
|
EP1724351A3
(en)
*
|
1999-03-11 |
2007-11-14 |
Mount Sinai Hospital |
Human Kallikrein-like genes
|
|
WO2000071711A2
(en)
*
|
1999-05-20 |
2000-11-30 |
Fahri Saatcioglu |
Differentially expressed genes in prostate cancer
|
|
CO5450246A1
(es)
*
|
1999-07-13 |
2004-10-29 |
Smithkline Beecham Corp |
Vacuna
|
|
US6720146B2
(en)
|
1999-09-10 |
2004-04-13 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
US6613515B1
(en)
|
1999-09-10 |
2003-09-02 |
Corixa Corporation |
Ovarian tumor sequences and methods of use therefor
|
|
WO2001018046A2
(en)
*
|
1999-09-10 |
2001-03-15 |
Corixa Corporation |
Ovarian tumor sequences and methods of use therefor
|
|
US20030232056A1
(en)
|
1999-09-10 |
2003-12-18 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
US6710170B2
(en)
|
1999-09-10 |
2004-03-23 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
US6617109B1
(en)
|
1999-09-10 |
2003-09-09 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
GB9922835D0
(en)
*
|
1999-09-25 |
1999-11-24 |
Smithkline Beecham Biolog |
Novel compounds
|
|
WO2001025272A2
(en)
*
|
1999-10-04 |
2001-04-12 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of prostate cancer
|
|
JP2003528584A
(ja)
*
|
1999-10-07 |
2003-09-30 |
シエーリング アクチエンゲゼルシャフト |
Ｐｒｏｓｔ０７ポリペプチドをコードするｄｎａ
|
|
CA2391369A1
(en)
*
|
1999-11-12 |
2001-05-17 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
EP1261708A2
(en)
*
|
2000-01-14 |
2002-12-04 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
|
US7611892B2
(en)
|
2000-03-24 |
2009-11-03 |
President And Fellows Of Harvard College |
Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
|
|
JP2004504808A
(ja)
*
|
2000-03-27 |
2004-02-19 |
コリクサ コーポレイション |
前立腺癌の治療及び診断のための組成物及び方法
|
|
RU2276672C2
(ru)
*
|
2000-04-10 |
2006-05-20 |
Институт Биоорганической химии им. акад. М.М. Шемякина и Ю.А. Овчинникова Российской Академии Наук |
Антитело к фактору hldf, способ его получения (варианты), пептид с антигенными и нк-гидролизующими свойствами и способ диагностики анапластического состояния клетки человека
|
|
WO2001077682A1
(fr)
*
|
2000-04-10 |
2001-10-18 |
Institut Bioorganicheskoi Khimii Imeni Akademikov M.M. Shemyakina I Ju. A. Ovchinnikova Rossiisskoi Akademii Nauk |
Anticorps diriges contre le facteur hldf, procedes de fabrication correspondants, peptides avec des capacites antigeniques et a hydrolyse hk et procede de diagnostic de l'etat anaplasique de cellules humaines
|
|
DK2266603T3
(da)
|
2000-10-18 |
2012-11-05 |
Glaxosmithkline Biolog Sa |
Tumorvacciner
|
|
US7037652B2
(en)
|
2000-11-28 |
2006-05-02 |
Wyeth |
Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
|
|
EP2316976A1
(en)
|
2000-11-28 |
2011-05-04 |
Wyeth LLC |
Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
|
|
US7494646B2
(en)
|
2001-09-06 |
2009-02-24 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
|
EP2287186B1
(en)
|
2001-09-06 |
2014-12-31 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer
|
|
US20040162236A1
(en)
*
|
2002-04-01 |
2004-08-19 |
John Alsobrook |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
EP1792912A3
(en)
*
|
2002-04-02 |
2007-08-29 |
Curagen Corporation |
Novel proteins and nucleic acids encoding same
|
|
WO2004013279A2
(en)
*
|
2002-05-14 |
2004-02-12 |
Fidelity Systems, Inc. |
Helix-hairpin-helix motifs to manipulate properties of dna processing enzymes
|
|
JP4643450B2
(ja)
|
2003-08-08 |
2011-03-02 |
株式会社ペルセウスプロテオミクス |
癌高発現遺伝子
|
|
US7276408B2
(en)
*
|
2003-10-08 |
2007-10-02 |
Texas Instruments Incorporated |
Reduction of dopant loss in a gate structure
|
|
WO2005062977A2
(en)
*
|
2003-12-23 |
2005-07-14 |
The Regents Of The University Of California |
Prostate cancer specific internalizing human antibodies
|
|
CA2563735C
(en)
|
2004-04-22 |
2020-07-14 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to steap-1 proteins
|
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
|
HUE036180T2
(hu)
|
2006-09-26 |
2018-06-28 |
Infectious Disease Res Inst |
Szintetikus adjuvánst tartalmazó vakcina készítmény
|
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
EP2061814B1
(en)
|
2006-10-27 |
2012-06-06 |
Genentech, Inc. |
Antibodies and immunoconjugates and uses therefor
|
|
HUE031051T2
(en)
|
2009-06-05 |
2017-06-28 |
Infectious Disease Res Inst |
Synthetic glycopyranosyl lipid adjuvant and vaccine compositions containing it
|
|
EP2675473A1
(en)
|
2011-02-15 |
2013-12-25 |
Immune Design Corp. |
Methods for enhancing immunogen specific immune responses by vectored vaccines
|
|
EP3632463A1
(en)
|
2011-04-08 |
2020-04-08 |
Immune Design Corp. |
Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
|
|
WO2013119856A1
(en)
|
2012-02-07 |
2013-08-15 |
Infectious Disease Research Institute |
Improved adjuvant formulations comprising tlr4 agonists and methods of using the same
|
|
SI2850431T1
(en)
|
2012-05-16 |
2018-08-31 |
Immune Design Corp. |
Vaccines for hsv-2
|
|
EP2986303B1
(en)
|
2013-04-18 |
2020-02-26 |
Immune Design Corp. |
Gla monotherapy for use in cancer treatment
|
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
|
IL246456B2
(en)
|
2013-12-31 |
2024-06-01 |
Access To Advanced Health Inst |
Formulations will be assembled into a single vial
|
|
US20170196954A1
(en)
|
2014-07-15 |
2017-07-13 |
Immune Design Corp. |
Prime-boost regimens with a tlr4 agonist adjuvant and a lentiviral vector
|
|
WO2017180420A1
(en)
|
2016-04-11 |
2017-10-19 |
Board Of Regents, The University Of Texas System |
Methods and compositions for detecting single t cell receptor affinity and sequence
|
|
BR112018073676B1
(pt)
|
2016-05-16 |
2023-10-03 |
University Of Virginia Patent Foundation |
Lipossomas peguilados e métodos de uso
|
|
MX2018014086A
(es)
|
2016-05-16 |
2019-09-18 |
Infectious Disease Res Inst |
Formulacion que contiene agonista tlr y metodos de uso.
|
|
CA3023271A1
(en)
|
2016-06-01 |
2017-12-07 |
Infectious Disease Research Institute |
Nanoalum particles containing a sizing agent
|
|
AU2018247767B2
(en)
|
2017-04-03 |
2025-01-30 |
F. Hoffmann-La Roche Ag |
Antibodies binding to STEAP-1
|
|
US11141377B2
(en)
|
2017-06-15 |
2021-10-12 |
Infectious Disease Research Institute |
Nanostructured lipid carriers and stable emulsions and uses thereof
|
|
CA3078223A1
(en)
|
2017-09-08 |
2019-03-14 |
Infectious Disease Research Institute |
Liposomal formulations comprising saponin and methods of use
|
|
WO2020243115A1
(en)
|
2019-05-25 |
2020-12-03 |
Infectious Disease Research Institute |
Composition and method for spray drying an adjuvant vaccine emulsion
|
|
WO2022051022A1
(en)
|
2020-09-04 |
2022-03-10 |
Infectious Disease Research Institute |
Co-lyophilized rna and nanostructured lipid carrier
|
|
WO2022051024A1
(en)
|
2020-09-04 |
2022-03-10 |
Infectious Disease Research Institute |
Genetically-adjuvanted rna vaccines
|
|
CN117120087A
(zh)
|
2020-12-23 |
2023-11-24 |
高级健康研究所 |
茄尼醇疫苗助剂及其制备方法
|